Delivery Order SPE2DB22D3301-SPE2DB24FY9WE

Award Date 7/3/24
Potential Completion Date 7/25/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,057.69 firm fixed-price delivery order is for the supply of 4,565 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,710.00 firm fixed-price contract is for the delivery of 50-unit vials of the pharmaceutical product XEOMIN. The contract has a completion date of September 19, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military treatment facilities and veterans' hospitals. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.40 firm-fixed-price delivery order is for the supply of 50-unit vials of the pharmaceutical product XEOMIN. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $24,639.28 firm-fixed-price contract is for the supply of 4,565,970,488 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The order has an ultimate completion date of October 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a $10,687.50 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,565,833,076 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. This delivery order has an ultimate completion date of October 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies. This award appears to be part of a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XEOMIN 200 unit vials. The contract has a ceiling value of $15,203.25 and an ultimate completion date of September 12, 2024. It is a firm fixed-price contract and does not have a set-aside designation. AmerisourceBergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical and the...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XEOMIN 100 unit vials. The $1,310.60 firm fixed price contract has an ultimate completion date of August 9, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of prescription medications, medical supplies, and equipment to the U.S. federal government, including military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,145.50 firm-fixed-price contract is for the supply of 200-unit vials of the drug XEOMIN. The contract has no set-aside designation and has a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31,...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,762.20, is for the supply of 200-unit vials of the drug XEOMIN. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 200-unit vials of the pharmaceutical product XEOMIN, with a firm fixed price of $5,242.50 and an ultimate completion date of November 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9WE
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 100-unit vials of the pharmaceutical product XEOMIN. The contract has a ceiling value of $3,145.44 and a completion date of July 25, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense globally. This specific delivery order is not designated as a set-aside contract. AmerisourceBergen's expertise in pharmaceutical distribution and established supply chain enables it to efficiently fulfill government contracts for critical medical commodities.

Generated 10/2/24, 10:40 AM